Pitié-Salpêtrière Hospital

Paris 75013

2 studies enrolling now · 6 studies all time

What they study most

Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors, Arrhythmogenic Right Ventricular Cardiomyopathy, Breast Cancer, Cholangiocarcinoma, DM1, Diffuse Large B-cell Lymphoma, Gastric Cancer, KIT D816V Mutation, Myotonic Dystrophy, Myotonic Dystrophy Type 1 (DM1), Primary CNS Tumors, Respiration Disorders

Studies at this site

• Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 — Recruiting now
• Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) — Recruiting now
• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• A Study of TAS-120 in Patients With Advanced Solid Tumors — Completed
• (PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation — Completed
• Targeted Hypoglossal Neurostimulation Study #2 — Completed